검색어: osteodystrophy (영어 - 몰타어)

patients with growth hormone failure secondary to cri should be examined periodically for evidence of progression of renal osteodystrophy.
pazjenti b‟falliment tal-ormon tat-tkabbir ikkawżat minn cri għandhom jiġu eżaminati kull tant żmien għall-evidenża ta‟ progressjoni ta‟ osteodistrofija tal-kliewi.

no osteodystrophy was observed in dogs treated for 12 months with risperdal consta up to 20 mg/ kg/ 2 weeks.
l- ebda osteodistrofija ma kienet osservata fil- klieb kkurati għal 12- il xahar b ’ risperdal consta f’ doża sa 20mg/ kg/ ġimgħatejn.

risperdal consta administration to male and female rats for 12 and 24 months produced osteodystrophy at a dose of 40 mg/ kg/ 2 weeks.
risperdal consta mogħti lill- firien irġiel u nisa għal 12 u 24 xahar ipproduċa osteodistrofija f’ doża ta ’ 40 mg/ kg/ ġimgħatejn.

slipped capital femoral epiphyses and aseptic necrosis of the femoral head may be seen in children with advanced renal osteodystrophy and in growth hormone deficiency, and it is uncertain whether these problems are affected by gh therapy.
fi tfal b‟osteodistrofija avanzata tal-kliewi u b‟defiċjenza tal-ormon tat-tkabbir tista‟ tkun osservata epifisi ewlenija tal-wirk imċaqalqa minn posta u nekrosi asettika tar-ras tal-wirk, u mhux ċert jekk dawn il-problemi humiex affettwati minn terapija b‟gh.

the effect dose for osteodystrophy in rats was on a mg/ m2 basis 8 times the maximum recommended human dose and is associated with a plasma exposure 2 times the maximum anticipated exposure in humans at the maximum recommended dose.
id- doża ta ’ effett għal osteodistrofija fil- firien kienet, fuq bażi ta ’ mg/ m2, 8 darbiet aktar mill- massimu tad- doża rakkomandata fil- bnedmin u hija assoċjata ma ’ esponiment fil- plażma d- doppju ta ’ l- esponiment massimu antiċipat fil- bnedmin għad- doża massima rakkomandata.